Trials / Conditions / Invasive Pulmonary Aspergillosis

Invasive Pulmonary Aspergillosis

29 registered clinical trials studyying Invasive Pulmonary Aspergillosis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Influenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China NCT07330986	Jianfeng Xie	—
Active Not Recruiting	Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Fact NCT07238114	Universitaire Ziekenhuizen KU Leuven	—
Recruiting	PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Asper NCT07313527	University Hospital, Strasbourg, France	—
Recruiting	Breath Analysis for the Detection of Invasive Fungal Infections NCT06537726	University of Zurich	—
Recruiting	Early Diagnosis of Invasive Lung Aspergillosis NCT05860387	University Hospital Ostrava	—
Unknown	Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Condi NCT05138666	Centre Hospitalier Universitaire de Besancon	N/A
Unknown	LFD of Aspergillus Antigen in Paediatrics NCT05569824	St George's University Hospitals NHS Foundation Trust	—
Unknown	VOC in Breath Samples for the Diagnosis of IPA NCT05982912	Rambam Health Care Campus	—
Unknown	Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar NCT04848831	Universitätsklinikum Hamburg-Eppendorf	—
Completed	Prevalence of Influenza RelAted Invasive Aspergillosis NCT04172610	Karolinska University Hospital	—
Completed	Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) NCT04267497	Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal	Phase 1
Completed	Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheob NCT04077697	Centre Hospitalier Universitaire, Amiens	—
Terminated	Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invas NCT03672292	Scynexis, Inc.	Phase 2
Recruiting	Influenza Associated Aspergillosis In-depth Investigation NCT03748069	Universitaire Ziekenhuizen KU Leuven	—
Terminated	VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults NCT03327727	Vical	Phase 2
Completed	Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractor NCT03059992	Scynexis, Inc.	Phase 3
Completed	Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients NCT06654076	Guangzhou Institute of Respiratory Disease	—
Unknown	Voriconazole for IPA in Chinese Patients With COPD NCT02234739	Red Cross Hospital, Hangzhou, China	Phase 4
Unknown	CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients NCT02100761	dingshifang	—
Completed	A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergill NCT01782131	Merck Sharp & Dohme LLC	Phase 3
Completed	Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study NCT02058316	Medical University of Graz	—
Withdrawn	Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects NCT01188759	Pfizer	Phase 3
Unknown	Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmona NCT01499433	The First Affiliated Hospital of Guangzhou Medical University	Phase 4
Completed	Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute L NCT01615809	Fundació Sant Joan de Déu	Phase 2
Completed	Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis NCT01247142	Universitaire Ziekenhuizen KU Leuven	—
Completed	Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonar NCT00923832	National Cancer Institute (NCI)	—
Unknown	Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplanta NCT00986713	Capital Medical University	Phase 4
Completed	Prophylaxis of Fungal Invasive Infections in Leukemia NCT00501098	Northern Italy Leukemia Group	Phase 2
No Longer Available	Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis NCT05897294	TFF Pharmaceuticals, Inc.	—